Submitted:
23 April 2025
Posted:
25 April 2025
You are already at the latest version
Abstract
Keywords:
- CHAPTER ONE
1. Introduction
- CHAPTER TWO
2. The Rise of AI-Powered Telemedicine During COVID-19
2.1. Early Adoption of Telemedicine Before the Pandemic
2.2. The Pandemic as a Catalyst for Change
2.3. The Role of AI in Expanding Telemedicine’s Reach
2.4. AI in Healthcare Systems Beyond Telemedicine
2.5. The Long-Term Implications of AI-Powered Telemedicine
- CHAPTER THREE
3. Benefits and Challenges of AI-Powered Telemedicine in the Pandemic Context
3.1. Benefits of AI-Powered Telemedicine During COVID-19
3.1.1. Enhanced Healthcare Access
3.1.2. Real-Time Health Monitoring
3.1.3. Remote Diagnosis and Triage
3.1.4. Mental Health Support
3.2. Challenges of AI-Powered Telemedicine During COVID-19
3.2.1. Data Privacy and Security Concerns
3.2.2. Limited Access to Technology
3.2.3. Reliability of AI Algorithms
3.2.4. Regulatory Challenges
3.3. Conclusion
- CHAPTER FOUR
4. Challenges and Barriers to the Widespread Adoption of AI-Powered Telemedicine
4.1. Technical Barriers
4.2. Regulatory and Legal Challenges
4.3. Financial and Resource Constraints
4.4. Ethical Considerations and Trust Issues
4.5. Public Perception and Trust in AI
- CHAPTER FIVE
5. The Future of AI-Powered Telemedicine: Trends and Opportunities
5.1. Advancements in AI Algorithms and Machine Learning
5.2. Integration of AI with Remote Monitoring and Wearable Devices
5.3. Expansion of Telemedicine Services to Rural and Underserved Populations
5.4. Regulatory and Policy Developments to Support AI Integration
5.5. Ethical Considerations in the Future of AI-Powered Telemedicine
- CHAPTER SIX
6. Challenges and Barriers to the Widespread Adoption of AI-Powered Telemedicine
6.1. Technological Challenges
6.2. Data Privacy and Security Concerns
6.3. Regulatory and Legal Challenges
6.4. Acceptance and Trust Among Healthcare Providers and Patients
6.5. Financial Barriers
- CHAPTER SEVEN
7. Conclusions
References
- Deloitte. (2020). Telemedicine and the COVID-19 pandemic: A new normal for healthcare. Deloitte Insights.
- Drees, J. M. (2021). Artificial Intelligence in Healthcare During COVID-19: Opportunities and Challenges. Becker’s Hospital Review.
- FDA. (2020). Artificial intelligence and machine learning in software as a medical device. FDA Guidance Document.
- Golinelli, D., Boetto, E., Carullo, G., Landini, M. P., & Fantini, M. P. (2020). Adoption of digital technologies in health care during the COVID-19 pandemic: Systematic review of early scientific literature. Journal of Medical Internet Research, 22(11), e22280. [CrossRef]
- Harrison, J. (2020). Adoption of artificial intelligence in healthcare: Barriers and challenges. Journal of Healthcare Management, 65(5), 314-321.
- He, W. (2021). The impact of interoperability on AI adoption in healthcare. Health Information Management Journal, 50(1), 18-25.
- Hirsch, J. (2020). Artificial intelligence in telemedicine: Opportunities and challenges. Telemedicine and e-Health, 26(4), 267-272.
- Iyengar, K., Mabrouk, A., Jain, V. K., Venkatesan, A., & Vaishya, R. (2020). Learning opportunities from COVID-19 and future effects on health care system. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(5), 943-946. [CrossRef]
- Kacheru, G. (2020). The role of AI-Powered Telemedicine software in healthcare during the COVID-19 Pandemic. Turkish Journal of Computer and Mathematics Education (TURCOMAT)., 11(3). [CrossRef]
- Kather, J. N., et al. (2021). Financial considerations for AI-powered telemedicine in healthcare systems. Journal of Health Economics, 40(3), 115-123.
- Lee, J., et al. (2021). Economic and policy perspectives on the integration of AI into healthcare. Health Economics Review, 11(1), 15-25.
- Lipton, Z. C. (2016). The mythos of model interpretability. Proceedings of the 2016 ICML Workshop on Human Interpretability in Machine Learning.
- Obermeyer, Z., Powers, B., Vogeli, C., & Mullainathan, S. (2019). Dissecting racial bias in an algorithm used to manage the health of populations. Science, 366(6464), 447-453. [CrossRef]
- Park, H., et al. (2021). Reimbursement policies for telemedicine: Challenges and opportunities. Health Affairs, 40(1), 90-97.
- Raji, I. D., et al. (2020). Accountability and liability in AI-powered healthcare systems. Journal of Medical Ethics, 46(8), 530-536.
- Rockwell, K. L., & Gilroy, A. S. (2020). Incorporating telemedicine as part of COVID-19 outbreak response systems. The American Journal of Managed Care, 26(4), 147-148. [CrossRef]
- Shick, R. M., et al. (2021). Predictive analytics in telemedicine: A game-changer for patient care. Journal of Telemedicine and Telecare, 27(4), 229-234.
- Smith, C., et al. (2021). The role of AI in mobile health applications. Journal of Medical Systems, 45(3), 1-10.
- Sullivan, M. K., et al. (2021). Public trust and acceptance of AI in healthcare: Insights from the COVID-19 pandemic. AI in Health, 3(2), 75-80.
- Susskind, R., & Susskind, D. (2015). The future of the professions: How technology will transform the work of human experts. Oxford University Press.
- Verghese, A., et al. (2018). The human touch in the age of artificial intelligence. The New England Journal of Medicine, 378(18), 1698-1702.
- Wang, J., et al. (2020). Remote monitoring and AI in chronic disease management. Journal of Medical Internet Research, 22(7), e15245.
- Weiner, J., et al. (2020). The role of AI in healthcare for underserved populations. American Journal of Public Health, 110(3), 402-408.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).